Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Secretogranin 3 ELISA Kit (AC2707)
Cat.#: ASET-1296
Specifications
Description Human Secretogranin 3 ELISA Kit allows for the in vitro quantitative determination of human Secretogranin 3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2528 Human Neuropeptide S ELISA Kit (AC3939) Quantitative inquiry ASET-2161 Mouse Niemann Pick C1 ELISA Kit (AC3572) Quantitative inquiry ASET-1813 Mouse LIF ELISA Kit (AC3224) Quantitative inquiry ASET-1037 Mouse GBA ELISA Kit (AC2448) Quantitative inquiry ASET-2543 Human Neuropilin 1 ELISA Kit (AC3954) Quantitative inquiry ASET-2134 Human Myotrophin ELISA Kit (AC3545) Quantitative inquiry ASET-1385 Mouse VMAT1 ELISA Kit (AC2796) Quantitative inquiry ASET-1746 Human TMPRSS4 ELISA Kit (AC3157) Quantitative inquiry ASET-2370 Mouse Nell1 ELISA Kit (AC3781) Quantitative inquiry ASET-2506 Bovine Antidiuretic Hormone ELISA Kit (AC3917) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket